|
|
|
Hookipa Pharma inc (NASDAQ: HOOK) |
|
|
|
| |
Hookipa Pharma Inc 's vs. its Competitors Results
(List of Competitors, Financial Results 12 Months from the last period ending MRQ, in Millions of $)
|
Select the Relationship:
|
|
Select the Category:
|
|
| COMPANY NAME |
TICKER |
REVENUE |
NET INCOME |
NET MARGIN |
CASH FLOW |
| Hookipa Pharma inc |
4 Q 2024 |
HOOK |
43.95 |
-43.50 |
- |
-78.45 |
| Sanofi |
4 Q 2024 |
SNY |
49,599.72 |
6,292.16 |
12.69 % |
11,309.76 |
| Novartis Ag |
4 Q 2023 |
NVS |
46,660.00 |
14,854.00 |
31.83 % |
12,407.00 |
| Astrazeneca Plc |
4 Q 2023 |
AZN |
45,811.00 |
5,961.00 |
13.01 % |
6,166.00 |
| Takeda Pharmaceutical Company Limited |
1 Q 2024 |
TAK |
29,166.69 |
986.39 |
3.38 % |
5,739.41 |
| Johnson and Johnson |
4 Q 2024 |
JNJ |
88,821.00 |
14,066.00 |
15.84 % |
2,246.00 |
| Merck and Co Inc |
4 Q 2024 |
MRK |
64,168.00 |
17,133.00 |
26.7 % |
6,409.00 |
| Eli Lilly And Company |
4 Q 2024 |
LLY |
45,042.70 |
10,590.00 |
23.51 % |
449.80 |
| Bristol myers Squibb Company |
4 Q 2024 |
BMY |
48,300.00 |
-8,933.00 |
-18.49 % |
-1,172.00 |
| Gilead Sciences Inc |
4 Q 2024 |
GILD |
28,754.00 |
480.00 |
1.67 % |
3,906.00 |
| Regeneron Pharmaceuticals Inc |
4 Q 2024 |
REGN |
14,202.00 |
4,412.60 |
31.07 % |
-248.80 |
| Organon and Co |
4 Q 2024 |
OGN |
6,403.00 |
864.00 |
13.49 % |
-18.00 |
| Hutchmed china Limited |
4 Q 2024 |
HCM |
630.20 |
38.17 |
6.06 % |
-119.04 |
| Emergent Biosolutions Inc |
4 Q 2024 |
EBS |
1,043.60 |
-190.60 |
-18.26 % |
-6.10 |
| Opko Health Inc |
4 Q 2024 |
OPK |
713.14 |
-53.22 |
-7.46 % |
349.73 |
| Novavax inc |
4 Q 2024 |
NVAX |
682.16 |
-187.50 |
-27.49 % |
-38.52 |
| Iovance Biotherapeutics Inc |
4 Q 2024 |
IOVA |
164.07 |
-372.18 |
-226.84 % |
-59.27 |
| Esperion Therapeutics inc |
4 Q 2024 |
ESPR |
332.31 |
-51.75 |
-15.57 % |
62.51 |
| Geron Corp |
4 Q 2024 |
GERN |
76.50 |
-174.57 |
-228.21 % |
9.74 |
| Mirati Therapeutics Inc |
3 Q 2023 |
MRTX |
38.19 |
-725.88 |
-1900.65 % |
-40.13 |
| Journey Medical Corp |
3 Q 2024 |
DERM |
57.77 |
-18.34 |
-31.74 % |
-2.29 |
| 2seventy Bio Inc |
3 Q 2024 |
TSVT |
45.62 |
-94.55 |
-207.25 % |
-31.79 |
| Spero Therapeutics Inc |
3 Q 2024 |
SPRO |
106.46 |
3.51 |
3.3 % |
-17.54 |
| Bluebird Bio Inc |
3 Q 2024 |
BLUE |
53.12 |
-16.05 |
-30.21 % |
-99.72 |
| Casi Pharmaceuticals inc |
4 Q 2023 |
CASI |
30.17 |
-35.84 |
-118.81 % |
-18.36 |
| Merus N v |
4 Q 2024 |
MRUS |
36.13 |
-215.33 |
-595.93 % |
89.02 |
| Sunshine Biopharma Inc |
3 Q 2024 |
SBFM |
32.96 |
-4.23 |
-12.82 % |
-6.67 |
| Point Biopharma Global Inc |
3 Q 2023 |
PNT |
243.69 |
96.55 |
39.62 % |
-104.18 |
| International Stem Cell Corporation |
3 Q 2024 |
ISCO |
8.53 |
-0.50 |
-5.89 % |
-0.12 |
| Durect Corp |
3 Q 2024 |
DRRX |
8.59 |
-17.07 |
-198.62 % |
-29.90 |
| Prometheus Biosciences Inc |
1 Q 2023 |
RXDX |
4.00 |
-150.56 |
-3768.76 % |
-148.86 |
| Immunome Inc |
1 Q 2024 |
IMNM |
12.51 |
-158.11 |
-1264.16 % |
234.61 |
| Bellicum Pharmaceuticals Inc |
3 Q 2023 |
BLCM |
1.48 |
2.59 |
175.2 % |
-22.85 |
| Xenetic Biosciences Inc |
4 Q 2024 |
XBIO |
2.50 |
-3.96 |
-158.39 % |
-2.82 |
| Longeveron Inc |
4 Q 2024 |
LGVN |
2.39 |
-24.62 |
-1029.39 % |
14.28 |
| Hcw Biologics Inc |
3 Q 2023 |
HCWB |
3.21 |
-37.33 |
-1161.31 % |
-10.22 |
| Humanigen Inc |
1 Q 2023 |
HGEN |
1.70 |
-53.63 |
-3156.8 % |
-65.85 |
| Tff Pharmaceuticals Inc |
3 Q 2024 |
TFFP |
1.28 |
-18.17 |
-1417.6 % |
-0.81 |
| 60 Degrees Pharmaceuticals Inc |
2 Q 2024 |
SXTP |
0.00 |
0.00 |
- |
0.00 |
| Dmk Pharmaceuticals Corporation |
3 Q 2023 |
DMK |
3.53 |
-22.23 |
-630.71 % |
4.22 |
| Histogen Inc |
3 Q 2023 |
HSTO |
0.02 |
-12.38 |
-65173.68 % |
-10.08 |
| Actavia Life Sciences Inc |
1 Q 2024 |
RASP |
0.12 |
-0.41 |
-333.15 % |
0.00 |
| Athersys Inc |
3 Q 2023 |
ATHX |
5.33 |
-83.37 |
-1565.65 % |
-12.76 |
| Adicet Bio Inc |
4 Q 2024 |
ACET |
38.70 |
-117.12 |
-302.63 % |
-100.31 |
| Viracta Therapeutics Inc |
3 Q 2024 |
VIRX |
0.00 |
-43.29 |
- |
0.27 |
| Kezar Life Sciences Inc |
3 Q 2024 |
KZR |
0.00 |
-95.78 |
- |
8.36 |
| Ampio Pharmaceuticals inc |
4 Q 2023 |
AMPE |
0.05 |
-8.63 |
-17264 % |
-8.56 |
| Sio Gene Therapies Inc |
4 Q 2023 |
SIOX |
0.00 |
-28.83 |
- |
-36.97 |
| 180 Life Sciences Corp |
3 Q 2024 |
ATNF |
0.00 |
-12.16 |
- |
-1.13 |
| Theriva Biologics inc |
1 Q 2024 |
TOVX |
0.00 |
-19.27 |
- |
-17.82 |
| Forte Biosciences Inc |
3 Q 2024 |
FBRX |
0.00 |
-34.20 |
- |
-29.82 |
| Indaptus Therapeutics Inc |
3 Q 2024 |
INDP |
0.00 |
-15.35 |
- |
-5.32 |
| Matinas Biopharma Holdings Inc |
3 Q 2024 |
MTNB |
4.28 |
-6.19 |
-144.49 % |
0.55 |
| Leap Therapeutics Inc |
3 Q 2024 |
LPTX |
1.50 |
-64.59 |
-4305.93 % |
-17.92 |
| Decibel Therapeutics Inc |
2 Q 2023 |
DBTX |
0.00 |
-63.39 |
- |
-16.77 |
| Mineralys Therapeutics Inc |
4 Q 2024 |
MLYS |
0.00 |
-177.81 |
- |
64.79 |
| Hst Global Inc |
3 Q 2024 |
HSTC |
0.00 |
-0.10 |
- |
0.01 |
| Nkarta Inc |
3 Q 2024 |
NKTX |
0.00 |
-110.61 |
- |
18.70 |
| Neurogene Inc |
3 Q 2024 |
NGNE |
0.00 |
-59.28 |
- |
-2.02 |
| Fibrobiologics Inc |
3 Q 2024 |
FBLG |
0.00 |
0.00 |
- |
0.00 |
| Renovorx Inc |
3 Q 2024 |
RNXT |
0.00 |
-9.16 |
- |
6.34 |
| Boundless Bio Inc |
3 Q 2024 |
BOLD |
0.00 |
-94.66 |
- |
61.86 |
| Immix Biopharma Inc |
3 Q 2024 |
IMMX |
0.00 |
-22.04 |
- |
0.11 |
| Genprex Inc |
3 Q 2024 |
GNPX |
0.00 |
-22.71 |
- |
-10.22 |
| Tiziana Life Sciences Ltd |
4 Q 2023 |
TLSA |
0.00 |
-17.69 |
- |
0.20 |
| Iterum Therapeutics Plc |
4 Q 2024 |
ITRM |
14.32 |
-24.77 |
-172.99 % |
18.05 |
| Cellectar Biosciences inc |
4 Q 2024 |
CLRB |
0.00 |
-44.58 |
- |
13.72 |
| Innovation1 Biotech Inc |
4 Q 2023 |
MYYZ |
0.08 |
-12.79 |
-16243.77 % |
-0.01 |
| Third Harmonic Bio Inc |
3 Q 2024 |
THRD |
0.00 |
39.20 |
- |
22.21 |
| Ayala Pharmaceuticals Inc |
3 Q 2023 |
ADXS |
3.74 |
-17.86 |
-477.59 % |
16.44 |
| Alaunos Therapeutics Inc |
3 Q 2024 |
TCRT |
0.00 |
-12.41 |
- |
-10.75 |
| Palatin Technologies Inc |
4 Q 2025 |
PTN |
2.18 |
-26.27 |
-1205.8 % |
-6.07 |
| Xbiotech Inc |
4 Q 2024 |
XBIT |
8.21 |
-38.53 |
-469.32 % |
-27.35 |
| Celyad Oncology Sa |
4 Q 2022 |
CYAD |
0.01 |
-29.69 |
-530240 % |
19.30 |
| APROX. MARKET |
4 Q |
SUBTOTAL |
471,386.40 |
62,890.53 |
13.34 % |
47,070.31 |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
